PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Tema Oncology ETF (CANC)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

ETF Info

IssuerTema
Inception DateAug 14, 2023
RegionGlobal (Broad)
CategoryHealth & Biotech Equities
Leveraged1x
Index TrackedNo Index (Active)
Asset ClassEquity

Asset Class Size

Mid-Cap

Asset Class Style

Growth

Expense Ratio

CANC features an expense ratio of 0.75%, falling within the medium range.


Expense ratio chart for CANC: current value at 0.75% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.75%

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons: CANC vs. IYH

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Tema Oncology ETF, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-10.00%-5.00%0.00%5.00%10.00%AprilMayJuneJulyAugustSeptember
5.62%
7.54%
CANC (Tema Oncology ETF)
Benchmark (^GSPC)

Returns By Period

Tema Oncology ETF had a return of 10.81% year-to-date (YTD) and 23.51% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date10.81%17.79%
1 month-0.44%0.18%
6 months5.62%7.53%
1 year23.51%26.42%
5 years (annualized)N/A13.48%
10 years (annualized)N/A10.85%

Monthly Returns

The table below presents the monthly returns of CANC, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-0.94%7.88%-0.33%-5.51%0.68%0.86%8.86%1.70%10.81%
2023588.93%-7.60%-5.01%9.18%10.51%629.58%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of CANC is 42, suggesting that the investment has average results relative to other ETFs in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.


The Risk-Adjusted Performance Rank of CANC is 4242
CANC (Tema Oncology ETF)
The Sharpe Ratio Rank of CANC is 3737Sharpe Ratio Rank
The Sortino Ratio Rank of CANC is 3939Sortino Ratio Rank
The Omega Ratio Rank of CANC is 3434Omega Ratio Rank
The Calmar Ratio Rank of CANC is 6565Calmar Ratio Rank
The Martin Ratio Rank of CANC is 3535Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Tema Oncology ETF (CANC) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


CANC
Sharpe ratio
The chart of Sharpe ratio for CANC, currently valued at 1.13, compared to the broader market0.002.004.001.13
Sortino ratio
The chart of Sortino ratio for CANC, currently valued at 1.69, compared to the broader market-2.000.002.004.006.008.0010.0012.001.69
Omega ratio
The chart of Omega ratio for CANC, currently valued at 1.19, compared to the broader market0.501.001.502.002.503.001.19
Calmar ratio
The chart of Calmar ratio for CANC, currently valued at 1.47, compared to the broader market0.005.0010.0015.001.47
Martin ratio
The chart of Martin ratio for CANC, currently valued at 4.50, compared to the broader market0.0020.0040.0060.0080.00100.00120.004.50
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.06, compared to the broader market0.002.004.002.06
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 2.78, compared to the broader market-2.000.002.004.006.008.0010.0012.002.78
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.37, compared to the broader market0.501.001.502.002.503.001.37
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.85, compared to the broader market0.005.0010.0015.001.85
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 11.09, compared to the broader market0.0020.0040.0060.0080.00100.00120.0011.09

Sharpe Ratio

The current Tema Oncology ETF Sharpe ratio is 1.13. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Tema Oncology ETF with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio1.001.502.00Sat 17Mon 19Wed 21Fri 23Aug 25Tue 27Thu 29Sat 31Mon 02Wed 04Fri 06Sep 08Tue 10Thu 12Sat 14Mon 16Wed 18
1.13
2.06
CANC (Tema Oncology ETF)
Benchmark (^GSPC)

Dividends

Dividend History

Tema Oncology ETF granted a 0.51% dividend yield in the last twelve months. The annual payout for that period amounted to $0.15 per share.


PeriodTTM2023
Dividend$0.15$0.15

Dividend yield

0.51%0.56%

Monthly Dividends

The table displays the monthly dividend distributions for Tema Oncology ETF. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2023$0.15$0.15

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-14.00%-12.00%-10.00%-8.00%-6.00%-4.00%-2.00%0.00%AprilMayJuneJulyAugustSeptember
-2.37%
-0.86%
CANC (Tema Oncology ETF)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Tema Oncology ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Tema Oncology ETF was 16.48%, occurring on Aug 15, 2023. Recovery took 1 trading session.

The current Tema Oncology ETF drawdown is 2.37%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-16.48%Aug 15, 20231Aug 15, 20231Aug 16, 20232
-16.04%Sep 5, 202339Oct 27, 202332Dec 13, 202371
-13.34%Feb 28, 202437Apr 19, 202457Jul 12, 202494
-8.91%Jul 17, 202416Aug 7, 2024
-4.05%Jan 9, 20247Jan 18, 20247Jan 29, 202414

Volatility

Volatility Chart

The current Tema Oncology ETF volatility is 5.62%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%3.00%4.00%5.00%6.00%7.00%AprilMayJuneJulyAugustSeptember
5.62%
3.99%
CANC (Tema Oncology ETF)
Benchmark (^GSPC)